Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC.AXIM · Entity 9689 | Director · 10% owner | December 31, 2016 | February 15, 2017 |
| Incannex Healthcare Inc.IXHL · Entity 7349 | Chief Technology Officer | November 28, 2023 | December 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AXIM BIOTECHNOLOGIES, INC.
Report date December 31, 2016 · Filed February 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,265,000 |
Reported balance
After 2016-11-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-11-21 · Grant · Acquired 240,000 · Balance 2,265,000 F1: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. |
| Common StockSEC Table I · non-derivative | Direct | 2,265,000 |
Reported balance
After 2016-11-21 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2016-11-21 · Grant · Acquired 2,000,000 · Balance 2,265,000 F1: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. |
| Preferred StockSEC Table I · non-derivative | IndirectSee footnote 2 | 500,000 |
Reported balance
After 2016-11-21 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2016-11-21 · Grant · Acquired 500,000 · Balance 500,000 F2: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B Preferred Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock.
F2: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B Preferred Stock.
Incannex Healthcare Inc.
Report date November 28, 2023 · Filed December 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Prash BV, a company wholly-owned by Mr. Changoer | 639,549 |
Reported balance
Holding disclosure · report date 2023-11-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 639,549 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2016 Filed Feb 15, 2017 19:34 UTC | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantPreferred Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000217 · primary_doc.xml · nonDerivative · entry 3 Changoer Lekhram · CIK 0001604389 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote 2 Disclosed balance after: 500,000 F2 · ownership.direct: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 500,000 shares of Series B Preferred Stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:34 UTC | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000217 · primary_doc.xml · nonDerivative · entry 2 Changoer Lekhram · CIK 0001604389 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265,000 F1 · ownership.direct: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. Read SEC document |
| November 21, 2016 Filed Feb 15, 2017 19:34 UTC | AXIM BIOTECHNOLOGIES, INC. AXIM · Entity 9689 | GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-17-000217 · primary_doc.xml · nonDerivative · entry 1 Changoer Lekhram · CIK 0001604389 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265,000 F1 · ownership.direct: Mr. Changoer is an affiliate and control person of Sanammad Foundation which holds 3,626,706 shares of common stock. Mr. Changoer is an affiliate and control person of Sanammad Foundation USA which holds 14,613,650 shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.